MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY:CI)

330.13 +0.69 (+0.21%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
UnitedHealth Slashes Guidance On Medicare Costs 'Far Above' Target; Dow Giant Dives
The Dow giant missed Q1 views and full-year 25 EPS targets on Medicare costs. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
What Does the Market Think About Cigna Group?
Via Benzinga
A Congress Member Sold Up To $225K In Accenture Stock: Here's What You Need To Know
Via Benzinga
Canada Launches Probe Into Cigna’s Express Scripts Over Anti-Competitive Conduct Allegations – But Retail’s Unmoved
Canada’s Competition Bureau is investigating allegations of conduct that can prevent or limit competition in the pharmacy retail market, including “patient steering” and “margin squeezing.” 
Via Stocktwits
Topics Animal Testing
Exposures Animal Testing Product Safety
Top S&P500 movers in Thursday's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
$100 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today
Via Benzinga
What Does the Market Think About Cigna Group?
Via Benzinga
Cigna Group Stock Sees RS Rating Jump To 86
Healthcare Cigna Group stock had its Relative Strength (RS) Rating upgraded to 86 Friday, up from 79 a day earlier. 
Via Investor's Business Daily
2 Reasons to Like CI (and 1 Not So Much)
Since October 2024, Cigna has been in a holding pattern, posting a small loss of 1% while floating around $338.25. However, the stock is beating the S&P 500’s 6.9% decline during that period. 
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner Shortage
The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?
Molina Healthcare has been treading water for the past six months, recording a small loss of 3.6% while holding steady at $329.49. 
Via StockStory
Topics Supply Chain
Exposures Supply Chain
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Cigna Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Cigna Group Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
THE CIGNA GROUP (NYSE:CI) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Exploring THE CIGNA GROUP's Technical Signals and Breakout Potential: THE CIGNA GROUP is showing promising signs of setting up for a breakout. 
Via Chartmill
Cigna Group Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
Via Benzinga
Here's How Much $1000 Invested In Cigna Group 20 Years Ago Would Be Worth Today
Via Benzinga
Q4 Earnings Outperformers: Cigna (NYSE:CI) And The Rest Of The Health Insurance Providers Stocks
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Health Insurance Providers Stocks Q4 Highlights: Molina Healthcare (NYSE:MOH)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Exposures Artificial Intelligence Interest Rates Legal
2 Large-Cap Stocks with Solid Fundamentals and 1 to Avoid
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Empire Psychiatry Expands Insurance Coverage to Make Mental Health Care Accessible to New York Residents Navigating Life's Issues.
Via GetFeatured
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Healthcare Stocks Decline After Trump Signs Executive Order On Price Transparency
Shares of major healthcare companies such as The Cigna Group Inc. (NYSE: CI), Molina Healthcare Inc. (NYSE: MOH) and UnitedHealth Group Inc. (NYSE: UNH) dropped Wednesday following the signing of an... 
Via Benzinga
Topics Government
Exposures Political
These S&P500 stocks are moving in today's pre-market session
Curious about the S&P500 stocks that are showing activity before the opening bell on Friday? 
Via Chartmill
DOJ Investigates UnitedHealth, Probe Accuses Of Inflating Medicare Diagnoses
The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher federal payments. The probe follows reports that the company received... 
Via Benzinga
Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10% 
Via MarketBeat
1 Healthcare Stock Primed for Growth and 2 to Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024.... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
1 Healthcare Stock Primed for Growth and 2 to Snub
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story